RadNet (RDNT) shares rallied 10% within the final buying and selling session to shut at $32.55. This transfer might be attributable to notable quantity with a better variety of shares being traded than in a typical session. This compares to the inventory’s 29.8% acquire over the previous 4 weeks.
This marks the third consecutive buying and selling day of RadNet’s worth enhance pushed by the optimism surrounding the corporate’s strong efficiency in its first-quarter 2021 outcomes. The encouraging efficiency got here on the again of a mix of a number of components – value financial savings measures made through the pandemic, sure investments (particularly in 3D mammography) and return to extra normalized procedural volumes. Moreover, the corporate’s raised full 12 months 2021 income steerage (in comparison with the prior announcement) additionally contributed to the worth appreciation.
This operator of medical diagnostic imaging facilities is anticipated to submit quarterly earnings of $0.14 per share in its upcoming report, which represents a year-over-year change of +187.5%. Revenues are anticipated to be $326.78 million, up 71.5% from the year-ago quarter.
Whereas earnings and income progress expectations are essential in evaluating the potential power in a inventory, empirical analysis exhibits a powerful correlation between developments in earnings estimate revisions and near-term inventory worth actions.
For RadNet, the consensus EPS estimate for the quarter has been revised 9.7% decrease during the last 30 days to the present stage. And a destructive development in earnings estimate revisions would not normally translate into worth appreciation. So, be certain to keep watch over RDNT going ahead to see if this current leap can flip into extra power down the street.
The inventory at present carries a Zacks Rank 3 (Maintain). You’ll be able to see the entire listing of at present’s Zacks Rank #1 (Robust Purchase) shares right here >>>>
Click on to get this free report
RadNet, Inc. (RDNT): Free Inventory Evaluation Report
To learn this text on Zacks.com click on right here.
Zacks Funding Analysis
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.